As pharma companies in Ireland grow impatient over our lethargic and bureaucratic medicine approvals process, their counterparts in the UK are going to court in an attempt to stop the NHS from imposing new limits on the price it will pay for medicines.
The unprecedented legal action follows a new rule that allows the NHS to consider delaying or restricting funding for medicines already deemed good value for money by the drug assessment body -...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team